ANDERSONS INC/THE (ANDE) Fundamental Analysis & Valuation

NASDAQ:ANDE • US0341641035

Current stock price

70.555 USD
+0.62 (+0.88%)
Last:

This ANDE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ANDE Profitability Analysis

1.1 Basic Checks

  • In the past year ANDE was profitable.
  • In the past year ANDE had a positive cash flow from operations.
  • In the past 5 years ANDE has always been profitable.
  • ANDE had a positive operating cash flow in 4 of the past 5 years.
ANDE Yearly Net Income VS EBIT VS OCF VS FCFANDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • ANDE has a Return On Assets (2.58%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 7.69%, ANDE is in line with its industry, outperforming 44.74% of the companies in the same industry.
  • ANDE has a Return On Invested Capital (4.78%) which is comparable to the rest of the industry.
  • ANDE had an Average Return On Invested Capital over the past 3 years of 6.85%. This is significantly below the industry average of 29.52%.
Industry RankSector Rank
ROA 2.58%
ROE 7.69%
ROIC 4.78%
ROA(3y)2.66%
ROA(5y)2.62%
ROE(3y)7.97%
ROE(5y)8.91%
ROIC(3y)6.85%
ROIC(5y)6.77%
ANDE Yearly ROA, ROE, ROICANDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • ANDE has a Profit Margin (0.87%) which is in line with its industry peers.
  • ANDE's Profit Margin has improved in the last couple of years.
  • ANDE has a Operating Margin (1.17%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ANDE has declined.
  • ANDE's Gross Margin of 6.48% is on the low side compared to the rest of the industry. ANDE is outperformed by 89.47% of its industry peers.
  • In the last couple of years the Gross Margin of ANDE has grown nicely.
Industry RankSector Rank
OM 1.17%
PM (TTM) 0.87%
GM 6.48%
OM growth 3Y-2.49%
OM growth 5YN/A
PM growth 3Y4.76%
PM growth 5Y54.36%
GM growth 3Y17.97%
GM growth 5Y7.39%
ANDE Yearly Profit, Operating, Gross MarginsANDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ANDE Health Analysis

2.1 Basic Checks

  • ANDE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ANDE has been reduced compared to 1 year ago.
  • ANDE has more shares outstanding than it did 5 years ago.
  • ANDE has a worse debt/assets ratio than last year.
ANDE Yearly Shares OutstandingANDE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ANDE Yearly Total Debt VS Total AssetsANDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 4.27 indicates that ANDE is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.27, ANDE is in the better half of the industry, outperforming 60.53% of the companies in the same industry.
  • A Debt/Equity ratio of 0.65 indicates that ANDE is somewhat dependend on debt financing.
  • ANDE has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: ANDE outperforms 47.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.27
ROIC/WACC0.73
WACC6.55%
ANDE Yearly LT Debt VS Equity VS FCFANDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • ANDE has a Current Ratio of 1.41. This is a normal value and indicates that ANDE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.41, ANDE is doing good in the industry, outperforming 73.68% of the companies in the same industry.
  • ANDE has a Quick Ratio of 1.41. This is a bad value and indicates that ANDE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ANDE has a Quick ratio (0.60) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.6
ANDE Yearly Current Assets VS Current LiabilitesANDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ANDE Growth Analysis

3.1 Past

  • The earnings per share for ANDE have decreased by -3.86% in the last year.
  • The Earnings Per Share has been growing by 109.65% on average over the past years. This is a very strong growth
  • The Revenue has decreased by -2.21% in the past year.
  • Measured over the past years, ANDE shows a small growth in Revenue. The Revenue has been growing by 6.42% on average per year.
EPS 1Y (TTM)-3.86%
EPS 3Y-7.17%
EPS 5Y109.65%
EPS Q2Q%50%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-14.03%
Revenue growth 5Y6.42%
Sales Q2Q%-18.79%

3.2 Future

  • Based on estimates for the next years, ANDE will show a very strong growth in Earnings Per Share. The EPS will grow by 32.97% on average per year.
  • ANDE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.00% yearly.
EPS Next Y50.59%
EPS Next 2Y32.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.52%
Revenue Next 2Y1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ANDE Yearly Revenue VS EstimatesANDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
ANDE Yearly EPS VS EstimatesANDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ANDE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.78, ANDE is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as ANDE.
  • ANDE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 14.46, the valuation of ANDE can be described as correct.
  • Based on the Price/Forward Earnings ratio, ANDE is valued a bit cheaper than 76.32% of the companies in the same industry.
  • ANDE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.78
Fwd PE 14.46
ANDE Price Earnings VS Forward Price EarningsANDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ANDE is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.06
ANDE Per share dataANDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • ANDE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ANDE's earnings are expected to grow with 32.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)0.2
EPS Next 2Y32.97%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ANDE Dividend Analysis

5.1 Amount

  • ANDE has a Yearly Dividend Yield of 1.12%.
  • Compared to an average industry Dividend Yield of 0.70, ANDE pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 1.12, ANDE pays less dividend than the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.12%

5.2 History

  • The dividend of ANDE has a limited annual growth rate of 2.85%.
  • ANDE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.85%
Div Incr Years0
Div Non Decr Years0
ANDE Yearly Dividends per shareANDE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • ANDE pays out 28.05% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of ANDE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.05%
EPS Next 2Y32.97%
EPS Next 3YN/A
ANDE Yearly Income VS Free CF VS DividendANDE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M
ANDE Dividend Payout.ANDE Dividend Payout, showing the Payout Ratio.ANDE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ANDE Fundamentals: All Metrics, Ratios and Statistics

ANDERSONS INC/THE

NASDAQ:ANDE (3/18/2026, 2:37:00 PM)

70.555

+0.62 (+0.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners90.53%
Inst Owner Change6.05%
Ins Owners4.31%
Ins Owner Change6.95%
Market Cap2.39B
Revenue(TTM)11.01B
Net Income(TTM)95.71M
Analysts84.44
Price Target74.8 (6.02%)
Short Float %2.14%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 1.12%
Yearly Dividend0.79
Dividend Growth(5Y)2.85%
DP28.05%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-01
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53.75%
Min EPS beat(2)28.48%
Max EPS beat(2)79.03%
EPS beat(4)3
Avg EPS beat(4)67.75%
Min EPS beat(4)-54.16%
Max EPS beat(4)217.65%
EPS beat(8)6
Avg EPS beat(8)69.27%
EPS beat(12)9
Avg EPS beat(12)48.4%
EPS beat(16)12
Avg EPS beat(16)49.22%
Revenue beat(2)0
Avg Revenue beat(2)-16.62%
Min Revenue beat(2)-24.22%
Max Revenue beat(2)-9.01%
Revenue beat(4)1
Avg Revenue beat(4)-8.43%
Min Revenue beat(4)-24.22%
Max Revenue beat(4)7.36%
Revenue beat(8)2
Avg Revenue beat(8)-8.72%
Revenue beat(12)2
Avg Revenue beat(12)-9.38%
Revenue beat(16)6
Avg Revenue beat(16)-1.44%
PT rev (1m)17.33%
PT rev (3m)37.5%
EPS NQ rev (1m)247.37%
EPS NQ rev (3m)247.37%
EPS NY rev (1m)8.59%
EPS NY rev (3m)12.42%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-5.07%
Revenue NY rev (3m)-4.69%
Valuation
Industry RankSector Rank
PE 21.78
Fwd PE 14.46
P/S 0.22
P/FCF N/A
P/OCF 13.51
P/B 1.92
P/tB 2.27
EV/EBITDA 11.06
EPS(TTM)3.24
EY4.59%
EPS(NY)4.88
Fwd EY6.92%
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)5.22
OCFY7.4%
SpS324.94
BVpS36.74
TBVpS31.09
PEG (NY)0.43
PEG (5Y)0.2
Graham Number51.75
Profitability
Industry RankSector Rank
ROA 2.58%
ROE 7.69%
ROCE 6.34%
ROIC 4.78%
ROICexc 4.99%
ROICexgc 5.47%
OM 1.17%
PM (TTM) 0.87%
GM 6.48%
FCFM N/A
ROA(3y)2.66%
ROA(5y)2.62%
ROE(3y)7.97%
ROE(5y)8.91%
ROIC(3y)6.85%
ROIC(5y)6.77%
ROICexc(3y)8.77%
ROICexc(5y)8.11%
ROICexgc(3y)9.9%
ROICexgc(5y)9.11%
ROCE(3y)8.57%
ROCE(5y)8.84%
ROICexgc growth 3Y-15.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-15.33%
ROICexc growth 5YN/A
OM growth 3Y-2.49%
OM growth 5YN/A
PM growth 3Y4.76%
PM growth 5Y54.36%
GM growth 3Y17.97%
GM growth 5Y7.39%
F-Score6
Asset Turnover2.97
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 3.09
Cap/Depr 174.86%
Cap/Sales 2.12%
Interest Coverage 2791.67
Cash Conversion 67.62%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.6
Altman-Z 4.27
F-Score6
WACC6.55%
ROIC/WACC0.73
Cap/Depr(3y)137.28%
Cap/Depr(5y)112.26%
Cap/Sales(3y)1.49%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y-7.17%
EPS 5Y109.65%
EPS Q2Q%50%
EPS Next Y50.59%
EPS Next 2Y32.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-14.03%
Revenue growth 5Y6.42%
Sales Q2Q%-18.79%
Revenue Next Year-1.52%
Revenue Next 2Y1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.75%
EBIT growth 3Y-16.17%
EBIT growth 5YN/A
EBIT Next Year356.73%
EBIT Next 3Y64.88%
EBIT Next 5YN/A
FCF growth 1Y-130.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3Y-14.89%
OCF growth 5YN/A

ANDERSONS INC/THE / ANDE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ANDERSONS INC/THE (ANDE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ANDE.


What is the valuation status for ANDE stock?

ChartMill assigns a valuation rating of 4 / 10 to ANDERSONS INC/THE (ANDE). This can be considered as Fairly Valued.


Can you provide the profitability details for ANDERSONS INC/THE?

ANDERSONS INC/THE (ANDE) has a profitability rating of 4 / 10.


What is the valuation of ANDERSONS INC/THE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ANDERSONS INC/THE (ANDE) is 21.78 and the Price/Book (PB) ratio is 1.92.


How financially healthy is ANDERSONS INC/THE?

The financial health rating of ANDERSONS INC/THE (ANDE) is 3 / 10.